AI Article Synopsis

  • A study identified three novel mutations in the PNLIP gene related to congenital pancreatic lipase deficiency (CPLD), which impairs pancreatic enzyme function.
  • Researchers examined how these mutations affected PNLIP's secretion and caused endoplasmic reticulum (ER) stress in lab cells.
  • All mutations resulted in defective secretion, with two specific variants causing protein misfolding and potentially leading to damage in pancreatic cells.

Article Abstract

Background/objectives: Studies of a rare homozygous missense mutation identified in two brothers diagnosed with congenital pancreatic lipase deficiency (CPLD) provided the first definitive evidence linking CPLD with missense mutations in the gene of PNLIP. Herein, we investigated the molecular basis for the loss-of-function in the three novel PNLIP variants (c.305G > A, p.(W102∗); c.562C > T, p.(R188C); and c.1257G > A, p.(W419∗)) associated with CPLD.

Methods: We characterized three novel PNLIP variants in transfected cells by assessing their secretion, intracellular distribution, and markers of endoplasmic reticulum (ER) stress.

Results: All three variants had secretion defects. Notably, the p.R188C and p.W419∗ variants induced misfolding of PNLIP and accumulated as detergent-insoluble aggregates resulting in elevated BiP at both protein and mRNA levels indicating increased ER stress.

Conclusions: All three novel PNLIP variants cause a loss-of-function through impaired secretion. Additionally, the p.R188C and p.W419∗ variants may induce proteotoxicity through misfolding and potentially increase the risk for pancreatic acinar cell injury.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11034858PMC
http://dx.doi.org/10.1016/j.pan.2023.10.022DOI Listing

Publication Analysis

Top Keywords

novel pnlip
16
pnlip variants
16
three novel
12
congenital pancreatic
8
pancreatic lipase
8
lipase deficiency
8
pr188c pw419∗
8
pw419∗ variants
8
variants
7
pnlip
6

Similar Publications

Fluorescence lifetime imaging of human pancreatic lipase activity using a novel probe for early diagnosis of severe acute pancreatitis.

Spectrochim Acta A Mol Biomol Spectrosc

February 2025

State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, No.163 Xianlin Road, Nanjing 210023, China. Electronic address:

Severe Acute Pancreatitis, a serious condition caused by factors such as gallstones and chronic excessive alcohol consumption, with a very high mortality rate. Human pancreatic lipase (hPL) is a key digestive enzyme and abnormal activity levels of this enzyme are important indicators for diagnosing and monitoring pancreatic diseases. A fluorescent probe, LPP, has been developed to monitor the activity of hPL, especially in cases of SAP.

View Article and Find Full Text PDF

Novel Role of the Gene Associated with Constipation Caused by Complement Component 3 Deficiency.

Int J Mol Sci

September 2024

Department of Biomaterials Science (BK21 FOUR Program), Life and Industry Convergence Research Institute, College of Natural Resources and Life Science, Pusan National University, Miryang 50463, Republic of Korea.

Article Synopsis
  • * Gene expression analysis revealed 1237 genes were upregulated and 1292 genes downregulated in C3 KO mice, with specific genes related to constipation identified.
  • * The research highlights a novel gene candidate that may help understand and potentially treat constipation linked to C3 deficiencies, particularly through the modulation of mucin-related gene expression.
View Article and Find Full Text PDF

Modeling protease-sensitive human pancreatic lipase mutations in the mouse ortholog.

J Biol Chem

October 2024

Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Electronic address:

Pancreatic lipase (PNLIP) is the major lipolytic enzyme secreted by the pancreas. A recent study identified human PNLIP variants P245A, I265R, F300L, S304F, and F314L in European cohorts with chronic pancreatitis. Functional analyses indicated that the variants were normally secreted but exhibited reduced stability when exposed to pancreatic proteases.

View Article and Find Full Text PDF

Obesity is acknowledged as a significant risk factor for various metabolic diseases, and the inhibition of human pancreatic lipase (hPL) can impede lipid digestion and absorption, thereby offering potential benefits for obesity treatment. Anthraquinones is a kind of natural and synthetic compounds with wide application. In this study, the inhibitory effects of 31 anthraquinones on hPL were evaluated.

View Article and Find Full Text PDF

Discovery of baicalein derivatives as novel inhibitors against human pancreatic lipase: Structure-activity relationships and inhibitory mechanisms.

Int J Biol Macromol

August 2024

Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address:

Human pancreatic lipase (hPL) is a vital digestive enzyme responsible for breaking down dietary fats in humans, inhibiting hPL is a feasible strategy for preventing and treating obesity. This study aims to investigate the structure-activity relationships (SARs) of flavonoids as hPL inhibitors, and to find potent hPL inhibitors from natural and synthetic flavonoids. In this work, the anti-hPL effects of forty-nine structurally diverse naturally occurring flavonoids were assessed and the SARs were summarized.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!